Food and Drug Administration
NOTICESDocket No. 99D-0674, CDER97135. Draft Guidance for Industry on IND's for Phase 2 and 3 Studies of Drugs, Including Specified Therapeutic Biotechnology-Derived Products; Chemistry, Manufacturing, and Controls Content and Format; Availability. Pages 19543-19544 [FR Doc. 99-9769] [TXT] [PDF] Written comments by July 20, 1999